Attenuated Mannheimia haemolytica strains
US9744226B2 · kind B2 · utility
1Cited by
2References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 8, 2016 |
| Grant date | Aug 29, 2017 |
| Priority date | — |
| Expiry date | Jan 8, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides attenuated M. haemolitica strains that elicit an immune response in animal against M. haemolitica, compositions comprising said strains, methods of vaccination against M. haemolitica, and kits for use with such methods and compositions. The invention further provides multi-valent vaccines, which provide protective immunity when administered in an effective amount to animals susceptible to “shipping fever” or bovine respiratory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.